divi's laboratories q3 profit after tax drops 66% yoy to ₹307 crore: vishal manchanda exclusive
Published 1 year ago • 10K plays • Length 5:46Download video MP4
Download video MP3
Similar videos
-
1:18
divi's laboratories q1: revenue grows, profit below est; mgmt positive on glp-1 drug opportunities
-
8:01
divi's labs q2 results: profit falls 19% yoy to ₹494 crore: prakash diwan exclusive | cnbc-tv18
-
3:35
decoding the key highlights of divi's lab q3fy23 earnings | nse closing bell | cnbc-tv18
-
2:10
jefferies downgrades stocks of divi's lab to 'underperform', motilal oswal downgrades to 'neutral'
-
1:56
divi's laboratories q4: revenue at ₹2,303 cr, margin up at 31.7%, ebitda rises to ₹538 cr
-
9:14
anticipations and insights: pre-budget 2024 discussion with sribash dasmohapatra, ed, plexconcil
-
16:58
fundamental analysis of divis lab! $20 billion opportunity!
-
5:36
is tata group a unique corporation?
-
2:39
decoding factor behind divi's laboratories surging in trade | trading hour | cnbc-tv18
-
12:55
waaree's profit more than doubles, revenue jumps fourfold. waaree's management on q3, stock split
-
8:50
dr om manchanda on dr lal pathlabs' weak q3 earnings & outlook | bazaar corporate radar | cnbc-tv18
-
1:44
what are the 3 culprits of production cost escalation?
-
2:37
would advise investors accumulating divi's labs shares at current levels: dimensions corporate
-
1:00
india boosts ev manufacturing with incentive schemes
-
23:36
sbi chairman dinesh kumar khara briefs media on the bank's q3fy23 results | earnings central
-
2:05
clear recommendations within 10 days: sc to govt | centre versus collegium | india business hour